上海交通大学学报（医学版）

›› 2012, Vol. 32 ›› Issue (7): 891-.doi: 10.3969/j.issn.1674-8115.2012.07.015

• 论著（基础研究） • 上一篇    下一篇

UbcH10基因沉默联合紫杉醇干预对NCI-H226细胞增殖活性和凋亡的影响

赵黎明1, 王良哲2, 娄丽蓉3, 孙光远4, 方 正1, 修清玉1   

  1. 1.第二军医大学长征医院呼吸内科, 上海 200003； 2.第二军医大学长征医院病理科, 上海 200003； 3.浦东新区卫生局卫生监督所, 上海 200136； 4．第二军医大学长征医院胸心外科, 上海 200003
  • 出版日期:2012-07-28 发布日期:2012-08-17
  • 通讯作者: 修清玉, 电子信箱: xiu_qingyu@126.com。
  • 作者简介:赵黎明（1976—）, 男, 主治医师, 博士；电子信箱: lmzhao76@163.com。
  • 基金资助:

    上海市卫生局课题（20090122）

Effects of UbcH10 gene silencing combined with paclitaxel treatment on proliferation and apoptosis of NCI-H226 cells

ZHAO Li-ming1, WANG Liang-zhe2, LOU Li-rong3, SUN Guang-yuan4, FANG Zheng1, XIU Qing-yu1   

  1. 1.Department of Respiratory Medicine, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China；2.Department of Pathology, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China；3.Shanghai Pudong New Area Health Inspection, Shanghai 200136, China；4.Department of Thoracic Surgery, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China
  • Online:2012-07-28 Published:2012-08-17
  • Supported by:

    Shanghai Municipal Health Bureau Foundation, 20090122

PDF (PC)

1095

摘要：

目的 观察小干扰RNA(siRNA)介导的UbcH10基因沉默联合紫杉醇处理对人肺鳞癌细胞株NCI-H226细胞增殖活性和凋亡的影响。方法 化学合成针对UbcH10基因的siRNA-UbcH10序列，脂质体转染siRNA至NCI-H226细胞（siRNA转染组），转染后24 h，采用Real-Time PCR和Western blotting分别检测UbcH10 mRNA和蛋白的表达水平，以未予任何转染细胞作为空白对照，以阴性序列转染细胞作为阴性对照。以紫杉醇（1 μmol/L）处理siRNA转染及未转染NCI-H226细胞（siRNA+紫杉醇组和紫杉醇组），分别于转染后24、48 h收集细胞，MTT比色法检测细胞增殖；转染后24 h收集细胞，流式细胞仪检测细胞凋亡；以未经紫杉醇处理的siRNA转染、阴性序列转染和未予转染的NCI-H226细胞作为siRNA转染组、阴性对照组和空白对照组。结果 Real-Time PCR和Western  blotting检测结果显示：转染后24 h，siRNA转染组UbcH10 mRNA和蛋白的表达较空白对照组和阴性对照组显著下调（P<0.01）。MTT比色法检测结果显示，siRNA转染组细胞增殖抑制率显著高于紫杉醇组和对照组（P<0.05），而siRNA+紫杉醇组细胞增殖抑制率显著高于siRNA转染组（P<0.05）。siRNA转染组细胞凋亡率显著高于紫杉醇组和对照组（P<0.05），而siRNA+紫杉醇组细胞凋亡率显著高于siRNA转染组（P<0.05），紫杉醇组与对照组细胞凋亡率比较差异无统计学意义（P＞0.05）。结论 UbcH10基因沉默可显著增强NCI-H226细胞对于化疗药物紫杉醇的敏感性。

关键词: UbcH10基因沉默, 小干扰RNA, 紫杉醇, NCI-H226细胞, 细胞增殖, 细胞凋亡

Abstract:

Objective To investigate the effects of small interfering RNA(siRNA)-mediated UbcH10 gene silencing combined with paclitaxel treatment on proliferation and apoptosis of human lung squamous carcinoma cell line NCI-H226. Methods siRNA-UbcH10 sequence targeting UbcH10 gene was synthesized chemically, and was transfected into NCI-H226 cells by lipofectin (siRNA transfection group). Twenty-four hours after transfection, the expression of UbcH10 mRNA and protein was detected by Real-Time PCR and Western blotting. Cells without transfection were served as blank controls, and those transfected with negative sequence as negative controls. NCI-H226 cells transfected with or without siRNA were treated with paclitaxel (1 μmol/L)(siRNA+ paclitaxel group or paclitaxel group), cell proliferation was detected by MTT assay 24 h and 48 h after transfection, and cell apoptosis was determined by flow cytometry 24 h after transfection. NCI-H226 cells without paclitaxel treatment while with siRNA transfection, negative sequence transfection and no transfection were served as siRNA transfection group, negative control group and blank control group respectively. Results Real-Time PCR and Western blotting revealed that the expression of UbcH10 mRNA and protein in siRNA transfection group was significantly lower than that in blank control group and negative control group (P<0.01). MTT assay indicated that the cell proliferation inhibition rate in siRNA transfection group was significantly higher than those in paclitaxel group and control group (P<0.05), while the cell proliferation inhibition rate in siRNA+paclitaxel group was significantly higher than that in siRNA transfection group (P<0.05). The cell apoptosis rate in siRNA transfection group was significantly higher than those in paclitaxel group and control group (P<0.05), and the cell apoptosis rate in siRNA+paclitaxel group was significantly higher than that in siRNA transfection group (P<0.05), while there was no significant difference in the cell apoptosis rate between paclitaxel group and control group (P＞0.05). Conclusion UbcH10 gene silencing can significantly increase the sensitivity of NCI-H226 cells to the chemotherapy drug paclitaxel.

Key words: UbcH10 gene silencing, small interfering RNA, paclitaxel, NCI-H226 cell, cell proliferation, cell apoptosis